heptaminol has been researched along with Breast Cancer in 1 studies
Heptaminol: An amino alcohol that has been used as a myocardial stimulant and vasodilator and to relieve bronchospasm. Its most common therapeutic use is in orthostatic hypotension. The mechanism of heptaminol's therapeutic actions is not well understood although it has been suggested to affect catecholamine release or calcium metabolism.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cluzan, RV | 1 |
| Pecking, AP | 1 |
| Mathiex-Fortunet, H | 1 |
| Léger Picherit, E | 1 |
1 trial available for heptaminol and Breast Cancer
| Article | Year |
|---|---|
Efficacy of BN165 (Ginkor Fort) in breast cancer related upper limb lymphedema: a preliminary study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arm; Breast Neoplasms; Complementary Therapies | 2004 |